Nektar TherapeuticsNKTRNASDAQ
Loading
Gross Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+9.2%
5Y CAGR+2.7%
Year-over-Year Change
Gross profit as a percentage of revenue
3Y CAGR
+9.2%/yr
vs -6.0%/yr prior
5Y CAGR
+2.7%/yr
Recent acceleration
Acceleration
+15.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 99.65% | +44.8% |
| 2024 | 68.82% | +16.0% |
| 2023 | 59.34% | -22.4% |
| 2022 | 76.50% | +1.2% |
| 2021 | 75.57% | -13.4% |
| 2020 | 87.26% | +7.3% |
| 2019 | 81.35% | -16.9% |
| 2018 | 97.95% | +8.8% |
| 2017 | 90.07% | +10.2% |
| 2016 | 81.74% | - |